Kenvue Canada Inc., a leader in consumer healthcare and a subsidiary of Kenvue Inc. (NYSE: KVUE), has announced the successful expansion of its manufacturing facility in Guelph, Ontario. This newly expanded facility marks a strategic milestone for Kenvue, reinforcing its commitment to strengthening global supply resilience while supporting the local economy in Ontario. This expansion also aligns with Kenvue’s long-standing legacy of providing consumers with trusted healthcare products such as Tylenol®, Aveeno®, Listerine®, and Neutrogena®.
Table of Contents
Expansion Strengthens Kenvue’s Legacy in Ontario and Beyond
Kenvue, renowned for being the world’s largest pure-play consumer health company by revenue, has invested in the Guelph facility to increase production capabilities and support a growing demand for over-the-counter (OTC) medications. This expansion builds on Kenvue’s presence of over 50 years in Canada, underscoring its commitment to supplying Canadians—and consumers globally—with reliable, science-backed products.
Kenvue’s President of Canada, Mark Hill, expressed excitement about the expanded facility: “This facility expansion strengthens our ability to deliver trusted healthcare products Canadians rely on every day. By increasing our capacity, we’re reinforcing our commitment to maintaining a steady supply of these essential products and strengthening our ability to respond to market demand.”
Boosting Production of Iconic Health and Wellness Brands
The expanded facility in Guelph will produce some of Kenvue’s most iconic brands, including Tylenol®, a staple in pain relief; Aveeno®, known for its gentle skincare formulations; Listerine®, a household name for oral hygiene; and Neutrogena®, a top dermatologist-recommended skincare line. These brands, backed by science and healthcare professionals, are part of Kenvue’s mission to make quality healthcare accessible and affordable for all.
By boosting local production, Kenvue aims to shorten supply chains, reduce potential delays, and make its products more readily available in stores. This increased capacity also plays a role in the company’s commitment to supply chain resilience on a global scale, ensuring that Kenvue’s trusted brands reach consumers worldwide without disruption.
Why the Expansion Matters for Ontario and Canadian Consumers
This facility expansion isn’t just an operational upgrade; it reflects Kenvue’s dedication to local economic development in Ontario. The expansion is expected to create new job opportunities in manufacturing, quality control, and logistics, contributing to the regional economy in Guelph and surrounding areas.
With growing consumer demand for OTC medications and personal care products, this expansion helps meet increased market needs while supporting the availability of essential healthcare items for Canadians. Kenvue’s commitment to Ontario also demonstrates its confidence in the region’s skilled workforce and infrastructure.
Top Government Benefits for Low Income Canadians in 2024
Two New CRA Benefit Payments Scheduled for Ontario Residents in November 2024
Highway 407 ETR Introduces the Route Relief Program for Low Income Drivers
November Brings Financial Relief for Ontario Residents 2024: Key CRA Benefits Explained
Don’t Want Doug Ford’s $200 Rebate? Here’s How to Return It and Help Pay Down Ontario’s Debt
A Legacy of Everyday Care: Kenvue’s Mission and Vision
Built on over a century of innovation and dedication, Kenvue’s products are trusted globally. At the core of its mission, Kenvue believes in the power of everyday care to improve lives, with the goal of “putting that power in consumers’ hands and earning a place in their hearts and homes.”
Through its expanded production facility in Ontario, Kenvue is better positioned to uphold this mission, ensuring that consumers can rely on the availability of these essential health and wellness products when they need them most. This expansion is aligned with the company’s values of sustainability, accessibility, and consumer trust, serving as a model of responsible and responsive healthcare manufacturing.
Kenvue’s Focus on Quality and Safety
In addition to enhancing production, the Guelph facility maintains rigorous quality standards to meet regulatory requirements, ensuring that every product delivered to consumers is safe, effective, and trustworthy. Kenvue’s commitment to quality control and consumer safety remains central to its operations, with each item carefully manufactured under controlled processes that meet or exceed industry standards.
About Kenvue Inc.
Kenvue Inc., the parent company of Kenvue Canada, is the largest standalone consumer health company globally by revenue. Kenvue’s diverse portfolio includes other leading brands such as Johnson’s®, BAND-AID®, and Zyrtec®, each carefully crafted to meet the healthcare needs of families worldwide. Driven by a passion for innovation and customer-centric care, Kenvue continues to leverage over 100 years of expertise to bring trusted, science-backed solutions to people around the globe.
For more information on Kenvue’s expanded facility in Ontario or details about Kenvue’s brand portfolio, visit kenvue.com.